61 research outputs found

    Connection of the ABO blood group system from the whole blood groups with the diabetes mellitus typ 2 for the period 2005-2009

    Get PDF
    Introduction:The real dimension of the connection between any blood group from the ABO system of blood groups and diabetes mellitus typ 2 in the eastern part of Republic of Macedonia in not well known. Aim:The aim of our study was to establish the connection of the blood group from the ABO system of blood groups with diabetes mellitus typ 2. Material and methods:The total number of registered patients with diabetes mellitus typ 2 in the Center of diabetes in Clinical hospital in Stip for the period 2005-2009 is 5,342. They were followed belong to ABO system of blood group by the determination of the ABO blood group and after receiving the written permission.The control group contained 12,500 healthy blood donors donated blood during the same period. The examination of the patients was realized in the RE of Transfusion in Stip using micro-agglutinated cards (Dia Med-ID Mikro Typing Systems). Results:The results using Chi-square test showed no connection between ABO blood groups and diabetes mellitus typ 2. Blood group "A" and "O" were negatively associated with diabetes mellitus typ 2 (P < 0,005) because the biggest part of that blood group were no diabetic patients. There is no significant association between blood group "B" and "AB" with diabetes mellitus typ 2, although most of patients with diabetes mellitus typ 2 were with blood group "B". Discussion and conclusion:After completed the study, obtained results confirmed that there is a negative correlation of blood group "A" and "O" from the ABO system od blood groups with diabetes mellitus type 2

    Analysis of metals in the serum of professionally exposed population of blood-donors from the Buchim-Radovish mine and unexposed general population from the municipality of Shtip

    Get PDF
    Aims:To determine the concentration of heavy metals in the serum of professionally exposed blood donor population from Buchim-Radovish mine and the unexposed general population (control group) from Shtip. To estimate the potential difference of heavy metals concentration and their impact on the health of blood recipients. Methods and materials:The concentration of heavy metals (Mn, Cr, Zn, Cu, Pb, Ni, Co, Cd) was analyzed in the serum of 30 professionally exposed miners blood donors from active Buchim mine, located nearby the town of Radovish. The control group comprised of 30 samples from the general population from Shtip, not directly exposed to heavy metals. The research was conducted in the chemical-biochemical laboratory at the University β€œGoce Delchev” in Shtip, using the equipment ISP-AES, Liberty 110, Varian. Results and discussion:Concentrations of Mn, Zn, Cu, Pb were significantly higher in the group of miners compared with the control group. The concentration of Cu correlates significantly with the concentration of Zn. This result is in line with the known fact that Cd, Cu, Zn bond to metallothionein in vivo, while Mn does not. Concentrations of Co and Cd were not significantly different between the analyzed groups, only Ni concentration is higher in the control group. Average values of analyzed metals were higher in the exposed group than in control group as reported in several studies on miners and other professionally exposed workers. Conclusion:Heavy metals have major impact of human health and environment. Strict legislation aiming to solve raising problems in this area gives vital importance to the monitoring of heavy metals. It is necessary to undertake further detailed analysis on the impact of higher concentrations of heavy metals in the blood of miners blood donors and on the health of blood recipients

    ΠŸΡ€ΠΎΡ„ΠΈΠ»Π°ΠΊΡΠ° Π½Π° Hepatitis B кај Π΄Π΅Ρ†Π° Ρ€ΠΎΠ΄Π΅Π½ΠΈ ΠΎΠ΄ HBsAg ΠΏΠΎΠ·ΠΈΡ‚ΠΈΠ²Π½ΠΈ мајки Π²ΠΎ MСдицински Ρ†Π΅Π½Ρ‚Π°Ρ€ Π²ΠΎ Π¨Ρ‚ΠΈΠΏ

    Get PDF
    Π¦Π΅Π» Π½Π° Ρ‚Ρ€ΡƒΠ΄ΠΎΡ‚: ΠŸΡ€ΠΎΡ„ΠΈΠ»Π°ΠΊΡΠ° Π½Π° Π²Π΅Ρ€Ρ‚ΠΈΠΊΠ°Π»Π½Π° Ρ‚Ρ€Π°Π½ΡΠΌΠΈΡΠΈΡ˜Π° Π½Π° Hepatitis B. ΠœΠ°Ρ‚Π΅Ρ€ΠΈΡ˜Π°Π» ΠΈ ΠΌΠ΅Ρ‚ΠΎΠ΄ΠΈ: Π”Π΅Ρ†Π°Ρ‚Π° Ρ€ΠΎΠ΄Π΅Π½ΠΈ ΠΎΠ΄ HBsAg ΠΏΠΎΠ·ΠΈΡ‚ΠΈΠ²Π½ΠΈ мајки вСднаш ΠΏΠΎ ΠΏΠΎΡ€ΠΎΠ΄ΡƒΠ²Π°ΡšΠ΅Ρ‚ΠΎ сС тСстирани Π·Π° ΡƒΡ‚Π²Ρ€Π΄ΡƒΠ²Π°ΡšΠ΅ присуство Π½Π° HBsAg со ΠœΠΈΠΊΡ€ΠΎΠ΅Π»ΠΈΡΠ° тСст ΠΎΠ΄ Ρ‚Ρ€Π΅Ρ‚Π° Π³Π΅Π½Π΅Ρ€Π°Ρ†ΠΈΡ˜Π° (Organon Teknika). Како ΠΏΠΎΡ‚Π²Ρ€Π΄Π΅Π½ тСст Π΅ користСн Lia Tek HCV (Organon Teknika). НарСднитС Ρ‚Π΅ΡΡ‚ΠΈΡ€Π°ΡšΠ° сС ΠΈΠ·Π²Ρ€ΡˆΠ΅Π½ΠΈ ΠΏΡ€Π΅Π΄ Π°ΠΏΠ»ΠΈΠΊΠ°Ρ†ΠΈΡ˜Π° Π½Π° Π²Ρ‚ΠΎΡ€Π° Π΄ΠΎΠ·Π° HB Π²Π°ΠΊΡ†ΠΈΠ½Π°, ΠΏΠΎΡ‚ΠΎΠ° 1 мСсСц ΠΏΠΎ добивањС Π½Π° Π²Ρ‚ΠΎΡ€Π° ΠΏΡ€ΠΎΡ„ΠΈΠ»Π°ΠΊΡ‚ΠΈΡ‡Π½Π° Π΄ΠΎΠ·Π°, ΠΏΠΎΡ‚ΠΎΠ° ΠΏΡ€Π΅Π΄ Π°ΠΏΠ»ΠΈΠΊΠ°Ρ†ΠΈΡ˜Π° Π½Π° Ρ‚Ρ€Π΅Ρ‚Π°Ρ‚Π° ΠΈ 1, 6 ΠΈ 12 мСсСци ΠΏΠΎ Ρ‚Ρ€Π΅Ρ‚Π°Ρ‚Π° ΠΏΡ€ΠΎΡ„ΠΈΠ»Π°ΠΊΡ‚ΠΈΡ‡Π½Π° Π΄ΠΎΠ·Π°. Π‘Π΅ Π΄Π΅Ρ‚Π΅ΠΊΡ‚ΠΈΡ€Π°ΡˆΠ΅ ΠΈ присуство Π½Π° Π°Π½Ρ‚ΠΈ-HBs (Nubenco Diagnostics, Inc. One Kalisa Way, Paramus, (U.S.A.). Π Π΅Π·ΡƒΠ»Ρ‚Π°Ρ‚ΠΈ: ΠΎΠ΄ 1050 Ρ€Π΅Π΄ΠΎΠ²Π½ΠΎ тСстирани Π±Ρ€Π΅ΠΌΠ΅Π½ΠΈ ΠΆΠ΅Π½ΠΈ присуство Π½Π° HBsAg Π΅ ΠΎΡ‚ΠΊΡ€ΠΈΠ΅Π½ΠΎ кај 14(1,33%). Кај Π½ΠΈΡ‚Ρƒ Π΅Π΄Π½Π° ΠΎΠ΄ испитуванитС Π±Ρ€Π΅ΠΌΠ΅Π½ΠΈ Ρ“Π΅Π½ΠΈ Π½Π΅ Π΅ рСгистриран Π°ΠΊΡƒΡ‚Π΅Π½ Ρ…Π΅ΠΏΠ°Ρ‚ΠΈΡ‚, Π½ΠΈΡ‚Ρƒ ΠΏΠΎΡ€Π΅ΠΌΠ΅Ρ‚ΡƒΠ²Π°ΡšΠ΅ Π½Π° Ρ…Π΅ΠΏΠ°Ρ‚Π°Π»Π½ΠΈΠΎΡ‚ ΠΈ Снзимскиот статуст. Π’Π΅Π΄Π½Π°Ρˆ ΠΏΠΎ ΠΏΠΎΡ€ΠΎΠ΄ΡƒΠ²Π°ΡšΠ΅Ρ‚ΠΎ ситС 14 Π½ΠΎΠ²ΠΎΡ€ΠΎΠ΄Π΅Π½ΠΈ Π΄Π΅Ρ†Π° сС тСстирани Π·Π° присуство Π½Π° HBsAg. Кај Π½ΠΈΡ‚Ρƒ Π΅Π΄Π½ΠΎ Π½Π΅ Π΅ ΠΎΡ‚ΠΊΡ€ΠΈΠ΅Π½ΠΎ присуство Π½Π° HBsAg..ΠŸΠΎΡ€Π°Π΄ΠΈ Ρ‚ΠΎΠ° Π°ΠΏΠ»ΠΈΡ†ΠΈΡ€Π°Π½ΠΈ сС i.m. 0,5 ml ) ENGERIX Π³Π΅Π½Π΅Ρ‚ΠΈΡ‡ΠΊΠΈ ΠΏΡ€ΠΎΠΈΠ·Π²Π΅Π΄Π΅Π½Π° HB Π²Π°ΠΊΡ†ΠΈΠ½Π°. Π‘Π΅Ρ€ΡƒΠΌ (HBIG) Π½Π΅ Π°ΠΏΠ»ΠΈΡ†ΠΈΡ€Π°Π²ΠΌΠ΅ ΠΏΠΎΡ€Π°Π΄ΠΈ нСмањС моТност ΠΎΠ΄ Π½Π°Π±Π°Π²ΠΊΠ°. Π•Π΄Π΅Π½ мСсСц ΠΏΠΎ Π°ΠΏΠ»ΠΈΠΊΠ°Ρ†ΠΈΡ˜Π°Ρ‚Π° Π½Π° Π²Ρ‚ΠΎΡ€Π°Ρ‚Π° Π΄ΠΎΠ·Π° HB Π²Π°ΠΊΡ†ΠΈΠ½Π°, ΠΏΠΎΡ‚ΠΎΠ° 1, 6 ΠΈ 12 мСсСци ΠΎΠ΄ Π°ΠΏΠ»ΠΈΠΊΠ°Ρ†ΠΈΡ˜Π°Ρ‚Π° Π½Π° Ρ‚Ρ€Π΅Ρ‚Π°Ρ‚Π° Π΄ΠΎΠ·Π° HB Π²Π°ΠΊΡ†ΠΈΠ½Π°, сСрумски ΠΏΡ€ΠΈΠΌΠ΅Ρ€ΠΎΡ†ΠΈ ΠΎΠ΄ Π½ΠΎΠ²ΠΎΡ€ΠΎΠ΄Π΅Π½ΠΈΡ‚Π΅ Π΄Π΅Ρ†Π° сС тСстирани Π·Π° ΠΎΡ‚ΠΊΡ€ΠΈΠ²Π°ΡšΠ΅ присуство Π½Π° HBsAg I anti - HBs.. Testirawata poka\aa negativni rezultati. Kaj Π½ΠΈ Π΅Π΄Π½ΠΎ ΠΎΠ΄ испитанитС Π΄Π΅Ρ†Π° Π½Π΅ Π΅ рСгисран Π°ΠΊΡƒΡ‚Π΅Π½ Ρ…Π΅ΠΏΠ°Ρ‚ΠΈΡ‚, Π½ΠΈΡ‚Ρƒ ΠΏΠΎΡ€Π΅ΠΌΠ΅Ρ‚ΡƒΠ²Π°ΡšΠ΅ Π½Π° Ρ…Π΅ΠΏΠ°Ρ‚Π°Π»Π½ΠΈΠΎΡ‚ ΠΈ Снзимскиот статус.. И ΠΏΠΎΠΊΡ€Π°Ρ˜ Π·Π°Π±Ρ€Π°Π½Π°Ρ‚Π° Π·Π° доСњС Π΄Π΅Π» ΠΎΠ΄ Π΄Π΅Ρ†Π°Ρ‚Π° сС Π΄ΠΎΠ΅Π½ΠΈ Π±Π΅Π· наша согласност. Π—Π°ΠΊΠ»ΡƒΡ‡ΠΎΠΊ: И ΠΏΠΎΠΊΡ€Π°Ρ˜ Ρ‚ΠΎΠ° ΡˆΡ‚ΠΎ Π½Π°ΡˆΠΈΡ‚Π΅ Ρ€Π΅Π·ΡƒΠ»Ρ‚Π°Ρ‚ΠΈ сС Ρ€Π°Π·Π»ΠΈΠΊΡƒΠ²Π°Π°Ρ‚ ΠΎΠ΄ ΠΌΠ½ΠΎΠ³Ρƒ ΠΏΠΎΠ΄Π°Ρ‚ΠΎΡ†ΠΈ Π²ΠΎ Π»ΠΈΡ‚Π΅Ρ€Π°Ρ‚ΡƒΡ€Π°Ρ‚Π° со иста ΠΈΠ»ΠΈ слична Ρ†Π΅Π», сСпак ΠΏΡ€Π΅ΠΏΠΎΡ€Π°Ρ‡ΡƒΠ²Π°ΠΌΠ΅ ΠΏΡ€ΠΎΡ„ΠΈΠ»Π°ΠΊΡ‚ΠΈΡ‡Π΅Π½ Ρ‚Ρ€Π΅Ρ‚ΠΌΠ°Π½ Π½Π° ситС Π½ΠΎΠ²ΠΎΡ€ΠΎΠ΄Π΅Π½ΠΈ Π΄Π΅Ρ†Π° ΠΎΠ΄ HBsAg ΠΏΠΎΠ·ΠΈΡ‚ΠΈΠ²Π½ΠΈ мајки со HBIG I HB Π²Π°ΠΊΡ†ΠΈΠ½Π°, ΠΈ Π·Π°Π±Ρ€Π°Π½Π° Π·Π° доСњС

    60 Π³ΠΎΠ΄ΠΈΠ½ΠΈ Π‘Π»ΡƒΠΆΠ±Π° Π·Π° Ρ‚Ρ€Π°Π½ΡΡ„ΡƒΠ·ΠΈΡ˜Π° Π½Π° ΠΊΡ€Π², 60 Π³ΠΎΠ΄ΠΈΠ½ΠΈ ΠΎΡ€Π³Π°Π½ΠΈΠ·ΠΈΡ€Π°Π½ΠΎ ΠΊΡ€Π²ΠΎΠ΄Π°Ρ€ΡƒΠ²Π°ΡšΠ΅ Π²ΠΎ ΠΎΠΏΡˆΡ‚ΠΈΠ½Π° Π¨Ρ‚ΠΈΠΏ

    Get PDF
    Π‘Ρ‚Π°Π½ΡƒΠ²Π° Π·Π±ΠΎΡ€ Π·Π° рСтроспСктивна ΡΡ‚ΡƒΠ΄ΠΈΡ˜Π° која Π³ΠΎ ΠΏΡ€ΠΈΠΊΠ°ΠΆΡƒΠ²Π° Ρ€Π°Π·Π²ΠΎΡ˜ΠΎΡ‚ Π½Π° крводаритСлството Π²ΠΎ ΠΎΠΏΡˆΡ‚ΠΈΠ½Π° Π¨Ρ‚ΠΈΠΏ, Π²ΠΎ ΠΏΠ΅Ρ€ΠΈΠΎΠ΄ΠΎΡ‚ ΠΎΠ΄ 50 Π³ΠΎΠ΄ΠΈΠ½ΠΈ ΠΎΠ΄ ΠΌΠΈΠ½Π°Ρ‚ΠΈΠΎΡ‚ Π²Π΅ΠΊ ΠΏΠ° сС Π΄ΠΎ дСнСс. НСговитС ΠΏΠΎΡ‡Π΅Ρ‚ΠΎΡ†ΠΈ, ΠΏΡ€ΠΎΠΌΠ΅Π½ΠΈ, нСдослСдности ΠΈ ΠΏΡ€ΠΈΠ»Π°Π³ΠΎΠ΄ΡƒΠ²Π°ΡšΠ° ΠΊΠΎΠ½ Ρ†Π΅Π»ΠΎΠΊΡƒΠΏΠ½ΠΈΠΎΡ‚ здравствСн систСм. Π¦Π΅Π»ΠΎΠΊΡƒΠΏΠ½Π°Ρ‚Π° ΡΡ‚ΡƒΠ΄ΠΈΡ˜Π° Π΅ Π±Π°Π·ΠΈΡ€Π°Π½Π° Π½Π° ситС досСгашни архивски ΠΏΠΎΠ΄Π°Ρ‚ΠΎΡ†ΠΈ ΠΎΠ΄ ΠšΠ»ΠΈΠ½ΠΈΡ‡ΠΊΠ°Ρ‚Π° Π±ΠΎΠ»Π½ΠΈΡ†Π° Π²ΠΎ Π¨Ρ‚ΠΈΠΏ ΠΈ ΠΏΠΎΡˆΠΈΡ€ΠΎΠΊΠΎ

    Prevention of transfusion transmissive bacterial infection in working unit Transfusiology in the Medical Center in Stip

    Get PDF
    Measures to be shown for prevention and reduction of bacterial contamination of donated blood and bacteriological procedures which are appled in WU Transfusiology for prevention of bacterial infection through blood and components

    Therapy with depleted erythrocyte concentrates and the occurrence of post-transfusion reactions with patients treated from bone marrow insufficiency at the daily blood transfusion hospital in Stip

    Get PDF
    Aim: To present the number and adverse post-transfusion reactions with patients suffering from bone marrow insufficiency, with transfunded depleted erythrocyte concentrates

    ΠŸΠΎΡΡ‚ΠΈΠ³Π½Π°Ρ‚ΠΈ Ρ€Π΅Π·ΡƒΠ»Ρ‚Π°Ρ‚ΠΈ Π½Π° ΠΏΠΎΠ»Π΅Ρ‚ΠΎ Π½Π° крводаритСлството Π²ΠΎ ΠΎΠΏΡˆΡ‚ΠΈΠ½Π° Π¨Ρ‚ΠΈΠΏ Π·Π° ΠΏΠ΅Ρ€ΠΈΠΎΠ΄ΠΎΡ‚ 1979-1988 Π³ΠΎΠ΄ΠΈΠ½Π°

    Get PDF
    ДСсСт Π³ΠΎΠ΄ΠΈΡˆΠ½ΠΈΡ‚Π΅ Π½Π°ΠΏΠΎΡ€ΠΈ Π½Π° Π Π• Ρ‚Ρ€Π°Π½ΡΡ„ΡƒΠ·ΠΈΠΎΠ»ΠΎΠ³ΠΈΡ˜Π°, ΠžΠΏΡ‚ΠΈΠ½ΡΠΊΠΈΠΎΡ‚ Π¦Ρ€Π²Π΅Π½ крст ΠΈ ситС потписници Π½Π° ΠžΠΏΡˆΡ‚Π΅ΡΡ‚Π²Π΅Π½ΠΈΠΎΡ‚ Π΄ΠΎΠ³ΠΎΠ²ΠΎΡ€ Π·Π° ΡƒΠ½Π°ΠΏΡ€Π΅Π΄ΡƒΠ²Π°ΡšΠ΅ Π½Π° крводаритСлството, овозмоТија цСлосно ΠΏΠΎΠΊΡ€ΠΈΠ²Π°ΡšΠ΅ Π½Π° ΠΏΠΎΡ‚Ρ€Π΅Π±ΠΈΡ‚Π΅ ΠΎΠ΄ свСѓа ΠΊΡ€Π² Π²ΠΎ Ρ€Π°Π±ΠΎΡ‚Π½ΠΈΡ‚Π΅ Π΅Π΄ΠΈΠ½ΠΈΡ†ΠΈ Π½Π° РО ΠœΠ΅Π΄ΠΈΡ†ΠΈΠ½ΡΠΊΠΈ Ρ†Π΅Π½Ρ‚Π°Ρ€ Π¨Ρ‚ΠΈΠΏ. Π’ΠΎ ΠΈΠ·ΠΌΠΈΠ½Π°Ρ‚ΠΈΡ‚Π΅ 10 Π³ΠΎΠ΄ΠΈΠ½ΠΈ ΠΏΠ»Π°Π½ΠΈΡ€Π°Π½ΠΈ сС Π²ΠΊΡƒΠΏΠ½ΠΎ 15.626 ΠΊΡ€Π²ΠΎΠ΄Π°Ρ€ΡƒΠ²Π°ΡšΠ°. Π‘ΠΎΠ±Ρ€Π°Π½ΠΈ сС Π²ΠΊΡƒΠΏΠ½ΠΎ 23.414 шишиња ΠΊΡ€Π². ΠŸΠ»Π°Π½ΠΎΡ‚ Π΅ исполнСт со 149,8%. Π’ΠΎ овој Ρ‚Ρ€ΡƒΠ΄ сС ΠΏΡ€ΠΈΠΊΠ°ΠΆΠ°Π½ΠΈ Ρ€Π΅Π·ΡƒΠ»Ρ‚Π°Ρ‚ΠΈΡ‚Π΅ Π²ΠΎ ΠΏΠ΅Ρ€ΠΈΠΎΠ΄ ΠΎΠ΄ 1979-1988 Π³ΠΎΠ΄ΠΈΠ½Π° ΠΏΠΎ Π³ΠΎΠ΄ΠΈΠ½ΠΈ, застапСност ΠΏΠΎ возраст ΠΈ ΠΏΠΎΠ», Π΄Π°Ρ€ΡƒΠ²Π°ΡšΠ° ΠΏΠΎ ΠΏΡ€Π² ΠΏΠ°Ρ‚ ΠΈ повСќС ΠΏΠ°Ρ‚ΠΈ, ΠΊΠ°ΠΊΠΎ ΠΈ ΡΠΎΡ†ΠΈΡ˜Π°Π»Π½Π°Ρ‚Π° структура Π½Π° ΠΊΡ€Π²ΠΎΠ΄Π°Ρ€ΠΈΡ‚Π΅Π»ΠΈΡ‚Π΅

    Π˜ΡΠΏΠΈΡ‚ΡƒΠ²Π°ΡšΠ΅ присуство Π½Π° Π°Π½Ρ‚ΠΈ-Π₯Π˜Π’ Π°Π½Ρ‚ΠΈΡ‚Π΅Π»Π° Π²ΠΎ сСрум ΠΎΠ΄ Π΄ΠΎΠ±Ρ€ΠΎΠ²ΠΎΠ»Π½ΠΈ Π΄Π°Ρ€ΠΈΡ‚Π΅Π»ΠΈ Π½Π° ΠΊΡ€Π² ΠΈ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΈ ΠΎΠ΄ Π½Π΅ΠΊΠΎΠ»ΠΊΡƒ Ρ€ΠΈΠ·ΠΈΡ‡Π½ΠΈ Π³Ρ€ΡƒΠΏΠΈ

    Get PDF
    Π’ΠΎ ΠΏΠ΅Ρ€ΠΈΠΎΠ΄ ΠΎΠ΄ 12.05.1988 Π΄ΠΎ 31.01.1989 Π³ΠΎΠ΄ΠΈΠ½Π° Π²ΠΎ Π Π• Π’Ρ€Π°Π½ΡΡ„ΡƒΠ·ΠΈΠΎΠ»ΠΎΠ³ΠΈΡ˜Π° испитано Π΅ присуство Π½Π° Π°Π½Ρ‚ΠΈ-Π₯Π˜Π’ Π°Π½Ρ‚ΠΈΡ‚Π΅Π»Π° кај 3.124 ΠΊΡ€Π²ΠΎΠ΄Π°Ρ€ΠΈΡ‚Π΅Π»ΠΈ, 34 ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΈ со Ρ…Ρ€ΠΎΠ½ΠΈΡ‡Π½Π° Π±ΡƒΠ±Ρ€Π΅ΠΆΠ½Π° ΠΈΠ½ΡΡƒΡ„ΠΈΡ†ΠΈΠ΅Π½Ρ†ΠΈΡ˜Π°, 3 Ρ…Π΅ΠΌΠΎΡ„ΠΈΠ»ΠΈΡ‡Π°Ρ€ΠΈ ΠΈ 7 анамнСстички ΠΈ ΠΊΠ»ΠΈΠ½ΠΈΡ‡ΠΊΠΈ суспСктни ΡΠ»ΡƒΡˆΠ°ΠΈ. Од Π²ΠΊΡƒΠΏΠ½ΠΎ 3.168 испитани најдСн Π΅ Π΅Π΄Π΅Π½ сСропозитивСн кој ΠΏΡ€ΠΈΠΏΠ°Ρ“Π° Π½Π° Ρ€Π°Π·Π»ΠΈΡ‡Π½Π°Ρ‚Π° Π³Ρ€ΡƒΠΏΠ°

    Π‘Π˜Π”Π - ситС Π·Π°Π΅Π΄Π½ΠΎ ќС ја ΠΏΠΎΠ±Π΅Π΄ΠΈΠΌΠ΅

    Get PDF
    ΠŸΠΎΠ·Π½Π°Ρ‚Π° Π΅ ΠΈΠ½Ρ„Π΅ΠΊΡ‚ΠΈΠ²Π½Π°Ρ‚Π° ΠΏΡ€ΠΈΡ€ΠΎΠ΄Π° Π½Π° болСста, ΠΏΠ°Ρ‚ΠΈΡˆΡ‚Π°Ρ‚Π° Π½Π° ΡˆΠΈΡ€Π΅ΡšΠ΅, ΠΏΡ€Π΅Π΄ΠΈΠ·Π²ΠΈΠΊΡƒΠ²Π°Ρ‡ΠΎΡ‚ ΠΈ Π½Π΅Π³ΠΎΠ²ΠΈΡ‚Π΅ карактСристики, ΠΏΠΎΠ·Π½Π°Ρ‚ΠΈ сС ΠΌΠ΅Ρ€ΠΊΠΈΡ‚Π΅ Π·Π° Π·Π°ΡˆΡ‚ΠΈΡ‚Π°. Π‘Π΅Ρ‚ΠΎ Ρ‚ΠΎΠ° прСтставува Π΅Π΄Π½Π° Π΄ΠΎΠ±Ρ€Π° основа со која ΠΌΠΎΠΆΠ΅ Π±Π°Ρ€Π΅ΠΌ Π΄Π° сС Π·Π°ΠΏΡ€Π΅ ΠΏΠΎΠ½Π°Ρ‚Π°ΠΌΠΎΡˆΠ½Π°Ρ‚Π° Ρ‚Ρ€Π°Π½ΡΠΌΠΈΡΠΈΡ˜Π° Π½Π° Π₯Π˜Π’ ΠΈΠ½Ρ„Π΅ΠΊΡ†ΠΈΡ˜Π°Ρ‚Π°. Π’ΠΎ ΠΎΠ²Π°Π° Π°ΠΊΡ†ΠΈΡ˜Π° Ρ‚Ρ€Π΅Π±Π° Π΄Π° учСствува сСкој ΠΏΠΎΠ΅Π΄ΠΈΠ½Π΅Ρ†, Π½ΠΎ Π³Π»Π°Π²Π½ΠΈΠΎΡ‚ ΠΈ ΠΏΡ€ΠΈΠΌΠ°Ρ€Π΅Π½ Ρ‚ΠΎΠ²Π°Ρ€, сСпак, ΠΏΠ°Ρ“Π° Π½Π° здравствСнитС Ρ€Π°Π±ΠΎΡ‚Π½ΠΈΡ†ΠΈ, Π²ΠΎ ΠΏΡ€Π² Ρ€Π΅Π΄ Π½Π° Π»Π΅ΠΊΠ°Ρ€ΠΈΡ‚Π΅

    ΠΠ°Ρ˜Ρ‡Π΅ΡΡ‚ΠΈ ΠΈΠ½Ρ„Π΅ΠΊΡ‚ΠΈΠ²Π½ΠΈ болСсти Π²ΠΎ Π Π΅ΠΏΡƒΠ±Π»ΠΈΠΊΠ° МакСдонија

    Get PDF
    Π˜Π½Ρ„Π΅ΠΊΡ‚ΠΈΠ²Π½ΠΈΡ‚Π΅ болСсти сС Π·Π°Π±ΠΎΠ»ΡƒΠ²Π°ΡšΠ° ΠΊΠΎΠΈ сС ΠΏΡ€Π΅Π΄ΠΈΠ·Π²ΠΈΠΊΠ°Π½ΠΈ ΠΎΠ΄ ΠΏΠ°Ρ‚ΠΎΠ³Π΅Π½ΠΈ ΠΌΠΈΠΊΡ€ΠΎΠΎΡ€Π³Π°Π½ΠΈΠ·ΠΌΠΈ - Π±Π°ΠΊΡ‚Π΅Ρ€ΠΈΠΈ, вируси, ΠΏΠ°Ρ€Π°Π·ΠΈΡ‚ΠΈ, Π³Π°Π±ΠΈΡ‡ΠΊΠΈ ΠΈ сл. Π‘Π΅ прСнСсуваат ΠΎΠ΄ ΠΈΠ½Ρ„ΠΈΡ†ΠΈΡ€Π°Π½ Ρ‡ΠΎΠ²Π΅ΠΊ ΠΈΠ»ΠΈ ΠΆΠΈΠ²ΠΎΡ‚Π½ΠΎ Π·Π° Π·Π΄Ρ€Π°Π² ΠΎΡ€Π³Π°Π½ΠΈΠ·Π°ΠΌ ΠΈ ΠΈΠΌΠ°Π°Ρ‚ склоност Π΄Π° сС распространуваат Π²ΠΎ Π²ΠΈΠ΄ Π½Π° Π΅ΠΏΠΈΠ΄Π΅ΠΌΠΈΠΈ. ОвиС болСсти ΠΏΠΎΡΡ‚ΠΎΡ˜Π°Ρ‚ ΠΎΡ‚ΠΊΠ°ΠΊΠΎ постои Ρ‡ΠΎΠ²Π΅ΡˆΡ‚Π²ΠΎΡ‚ΠΎ. Нив Π³ΠΈ спомнуваат ΠΈ Π½Π°Ρ˜ΡΡ‚Π°Ρ€ΠΈΡ‚Π΅ Π΄ΠΎΠΊΡ‚ΠΎΡ€ΠΈ: Π₯ΠΈΠΏΠΎΠΊΡ€Π°Ρ‚, Π“Π°Π»Π΅Π½, АвицСна. Но, Π·Π° Π½ΠΈΠ² повСќС сС Π·Π½Π°Π΅ ΠΎΠ΄ ΠΏΠ΅Ρ€ΠΈΠΎΠ΄ΠΎΡ‚ Π½Π° XVI Π²Π΅ΠΊ ΠΈΠ»ΠΈ ΠΏΠΎΡ‚ΠΎΡ‡Π½ΠΎ ΠΎΠ΄ XVIII Π²Π΅ΠΊ ΠΊΠΎΠ³Π° Π΅ ΠΎΡ‚ΠΊΡ€ΠΈΠ΅Π½ ΠΏΡ€ΠΈΡ‡ΠΈΠΈΡ‚Π΅Π»ΠΎΡ‚ Π½Π° Ρ‡ΡƒΠΌΠ°Ρ‚Π°. Π’ΠΎ послСднитС Π΄Π²Π° Π²Π΅ΠΊΠ° ΠΎΠ΄ Π²Ρ‚ΠΎΡ€ΠΈΠΎΡ‚ ΠΌΠΈΠ»Π΅Π½ΠΈΡƒΠΌ Π΄Π°Ρ‚ΠΈΡ€Π°Π°Ρ‚ ΠΈΠ½Ρ‚Π΅Π½Π·ΠΈΠ²Π½ΠΈ ΠΎΡ‚ΠΊΡ€ΠΈΡ‚ΠΈΡ˜Π° Π½Π° ΠΏΡ€ΠΈΡ‡ΠΈΠ½ΠΈΡ‚Π΅Π»ΠΈΡ‚Π΅ Π½Π° ΠΎΠ²ΠΈΠ΅ болСсти, Π° со Ρ‚ΠΎΠ° сС создаваат моТности Π·Π° Π½ΠΈΠ²Π½ΠΎ ΠΏΡ€ΠΎΡƒΡ‡ΡƒΠ²Π°ΡšΠ΅, ΡΠΏΡ€Π΅Ρ‡ΡƒΠ²Π°ΡšΠ΅ ΠΈ Π»Π΅ΠΊΡƒΠ²Π°ΡšΠ΅
    • …
    corecore